Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine.

Saraceno, Janaína Jamile Ferreira; Souza, Guilherme Macedo; Dos Santos Finamor, Luciana Peixoto; Nascimento, Heloisa Moraes; Belfort, Rubens

Saraceno, Janaína Jamile Ferreira; Souza, Guilherme Macedo; Dos Santos Finamor, Luciana Peixoto; Nascimento, Heloisa Moraes; Belfort, Rubens.

Saraceno JJF; Department of Ophthalmology, Hospital Sao Rafael, Salvador, Brazil.
Souza GM; Department of Ophthalmology and Visual Science, Federal University of Sao Paulo, Sao Paulo, Brazil.
Dos Santos Finamor LP; Department of Ophthalmology and Visual Science, Federal University of Sao Paulo, Sao Paulo, Brazil.
Nascimento HM; Department of Ophthalmology and Visual Science, Federal University of Sao Paulo, Sao Paulo, Brazil. helomn@gmail.com.
Belfort R; Research Department, Instituto Paulista de Estudos e Pesquisas em Oftalmologia/Instituto da Visão (IPEPO), Sao Paulo, Brazil. helomn@gmail.com.

Int J Retina Vitreous ; 7(1): 49, 2021 Aug 30.

Article in English | MEDLINE | ID: covidwho-1379802

ABSTRACT

ABSTRACT

The challenge of COVID-19 has rapidly changed medical management worldwide. The relatively small time from pandemic to vaccines regulatory approval triggered a race toward vaccines development. However, important questions regarding SARS-CoV-2 vaccines remain. A case of complete Vogt-Koyanagi-Harada (VKH) Syndrome that occurred 4 days following SARS-CoV-2 vaccination and another patient that developed VKH 14 days post COVID-19 clinical onset are presented. A causal relationship between COVID-19 and uveitis may exist.

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Long Covid / Vaccines Language: English Journal: Int J Retina Vitreous Year: 2021 Document Type: Article Affiliation country: S40942-021-00319-3

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google